NEW YORK (GenomeWeb News) – Danaher Motion – Dover, a branch of US technology conglomerate Danaher that has been developing a low-cost open-source next-generation sequencer with George Church’s group at Harvard Medical School, is scheduled to ship the first commercial version of the tool later this week to the Church lab, GenomeWeb Daily News sister publication In Sequence reported yesterday.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Science speaks with the University of Michigan's Jedidiah Carlson, who has tracked population genetic discussions at white nationalist sites.

Gene therapies could qualify for a faster US Food and Drug Administration approval process, according to Stat News.

NPR reports that the US House of Representatives has passed a bill to enable terminally ill patients access to experimental drugs.

In Genome Research this week: inversion variants mapped in human, non-human primate genomes; transcriptome profiling of maize, sorghum; and more.